Erica Brackin
Payments from drug & device makers
Across 168 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$398
- Abbott$328
- Sanofi-aventis U.S. LLC$286
- Novartis$244
- Boston Scientific$234
- Atricure, Inc.$231
- plus $2K from 25 others
What the payments were for
- Consulting fees$160%
- Food & beverage$3,239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $398 |
| Abbott | 17 | $328 |
| Sanofi-aventis U.S. LLC | 17 | $286 |
| Novartis | 13 | $244 |
| Boston Scientific | 13 | $234 |
| Atricure, Inc. | 5 | $231 |
| Johnson & Johnson | 10 | $184 |
| Kestra Medical Technology Services, Inc. | 8 | $182 |
| Pfizer | 9 | $173 |
| E.r. Squibb & Sons, L.L.C. | 10 | $172 |
| Alnylam Pharmaceuticals Inc. | 8 | $141 |
| AstraZeneca | 5 | $85 |
| Acacia Pharma Inc | 3 | $58 |
| Boehringer Ingelheim | 3 | $55 |
| Novo Nordisk | 2 | $53 |
| Lilly USA, LLC | 3 | $51 |
| Merck | 3 | $50 |
| Tactile Systems Technology Inc | 3 | $39 |
| Altathera Pharmaceuticals LLC | 2 | $35 |
| Lundbeck LLC | 2 | $31 |
| Cardiac Dimensions, Inc. | 1 | $30 |
| Philips North America LLC | 1 | $30 |
| Biosense Webster, Inc. | 1 | $28 |
| Cordis US CORP. | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Itamar Medical Inc | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Elutia, Inc. | 1 | $14 |
| Intuitive Surgical | 1 | $13 |
How this compares
$3,254 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $31,264 |
| MultaqDronedarone Hcl | 25 | $25,764 |
| SotalolSotalol Hcl | 25 | $424 |
| Flecainide Acetate | 27 | $410 |
| Fludrocortisone Acetate | 13 | $250 |
| Potassium Chloride | 11 | $202 |
| Amlodipine Besylate | 11 | $163 |
| Furosemide | 13 | $94 |
| Carvedilol | 17 | $86 |
| Atenolol | 12 | $86 |
| Metoprolol Tartrate | 15 | $64 |
| Losartan Potassium | 21 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $173 | $31,26425 claims |
| Sanofi-aventis U.S. LLCMultaq | $286 | $25,76425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,119 family providers in Arizona.
Other family in Mesa
- Sharon MagalonaMesa$449K
- Rebecca McCollaumMesa$149K
- Angela StuffMesa$22K
- Maria Norivic SorianoMesa$15K
- Kelly MatthewsMesa$15K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.